Circulating osteogenic cells in end-stage aortic valvular disease

Bone ◽  
2010 ◽  
Vol 47 ◽  
pp. S233 ◽  
Author(s):  
R. Pignolo ◽  
K. Egan
2011 ◽  
Vol 96 (1) ◽  
pp. 176-186 ◽  
Author(s):  
M. R. Rubin ◽  
J. S. Manavalan ◽  
D. W. Dempster ◽  
J. Shah ◽  
S. Cremers ◽  
...  

Bone ◽  
2011 ◽  
Vol 48 (3) ◽  
pp. 671
Author(s):  
Anita Undale ◽  
Bhuma Srinivasan ◽  
Matthew Drake ◽  
Louise McCready ◽  
Elizabeth Atkinson ◽  
...  

Bone ◽  
2010 ◽  
Vol 47 (1) ◽  
pp. 83-92 ◽  
Author(s):  
Anita Undale ◽  
Bhuma Srinivasan ◽  
Matthew Drake ◽  
Louise McCready ◽  
Elizabeth Atkinson ◽  
...  

1995 ◽  
Vol 9 (9) ◽  
pp. 521-525 ◽  
Author(s):  
U LIVI ◽  
A CAFORIO ◽  
G BOFFA ◽  
V TURSI ◽  
G THIENE ◽  
...  

Author(s):  
Chi-Ming Wei ◽  
Margarita Bracamonte ◽  
Shi-Wen Jiang ◽  
Richard C. Daly ◽  
Christopher G.A. McGregor ◽  
...  

Nitric oxide (NO) is a potent endothelium-derived relaxing factor which also may modulate cardiomyocyte inotropism and growth via increasing cGMP. While endothelial nitric oxide synthase (eNOS) isoforms have been detected in non-human mammalian tissues, expression and localization of eNOS in the normal and failing human myocardium are poorly defined. Therefore, the present study was designed to investigate eNOS in human cardiac tissues in the presence and absence of congestive heart failure (CHF).Normal and failing atrial tissue were obtained from six cardiac donors and six end-stage heart failure patients undergoing primary cardiac transplantation. ENOS protein expression and localization was investigated utilizing Western blot analysis and immunohistochemical staining with the polyclonal rabbit antibody to eNOS (Transduction Laboratories, Lexington, Kentucky).


Sign in / Sign up

Export Citation Format

Share Document